Omalizumab: observed
47 studies: patients on it are followed, or it is given outside a trial. Page 1 of 1. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- Characteristics and Management of Patients With Severe Chronic Spontaneous and/or Inducible Urticaria Refractory to Optimized Omalizumab Treatment: A French Multicenter Observational Study.RecruitingNCT07833696How we knowReport a problem
- T2AIR: Real-World Efficacy and Safety of Biologics Targeting Type 2 Inflammation in Asthma and COPDRecruitingNCT07823842How we knowReport a problem
- Effects of Diet and Oxidative Stress on Disease Severity and Response to Omalizumab in Chronic Spontaneous UrticariaEnrolling by invitationNCT07431658How we knowReport a problem
- ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab BiosimilarRecruitingNCT07425639How we knowReport a problem
- Deep Phenotyping of CIndURecruitingNCT07359430How we knowReport a problem
- Analysis of the Role of IgE Proteoforms in Health and DiseaseRecruitingNCT07328178How we knowReport a problem
- Omalizumab for Plant-Food Allergy Due to Sensitization to LTP or ProfilinNot yet recruitingNCT07073404How we knowReport a problem
- SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)RecruitingNCT07021495How we knowReport a problem
- Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)RecruitingNCT06683261How we knowReport a problem
- The Impact of Airway Allergic Diseases on Children's and Parents' Quality of LifeRecruitingNCT06535087How we knowReport a problem
- Taiwan Severe Asthma Biologic RegistryRecruitingNCT06456450How we knowReport a problem
- A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE)RecruitingNCT06348407How we knowReport a problem
- Fluctuation Analyses of Asthma Patients With Biologics UseNot yet recruitingNCT06024707How we knowReport a problem
- Phenotypic and Functional Characterization of Neutrophils and Eosinophils in Severe Asthma Treated With BiotherapyRecruitingNCT05972213How we knowReport a problem
- Real Life Study of Biologicals in Patients With Severe CRSwNPRecruitingNCT05938972How we knowReport a problem
- Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis TherapyRecruitingNCT05674695How we knowReport a problem
- Comparison of Biologicals in Treatment of Severe AsthmaCompletedNCT04158050Results postedHow we knowReport a problem
- Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair DosingCompletedNCT00813748Results postedHow we knowReport a problem
- A Real-World Study of Omalizumab Treatment Patterns in Chronic Urticaria Patients in ChinaCompletedNCT07450170How we knowReport a problem
- A Study About the Use of Omalizumab in the Treatment of Food Allergy and AnaphylaxisCompletedNCT07027163How we knowReport a problem
- Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe AsthmaActive, not recruitingNCT06771934How we knowReport a problem
- International Severe CRSwNP Registry 2024-2028Active, not recruitingNCT06617754How we knowReport a problem
- Omalizumab in Severe Asthmatics With Food AllergyCompletedNCT06316414How we knowReport a problem
- A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health ServiceCompletedNCT06261567How we knowReport a problem
- A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in ChinaCompletedNCT06053801How we knowReport a problem
- Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal PolypsCompletedNCT05626257How we knowReport a problem
- Effectiveness and Safety of Omalizumab in Children With Allergic Asthma.CompletedNCT05424523How we knowReport a problem
- Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of TherapyCompletedNCT05270278How we knowReport a problem
- BIOlogics in Severe Nasal POlyposis SurvEyActive, not recruitingNCT05228041How we knowReport a problem
- XOLAIR (Omalizumab) Outcomes in Pediatric Allergic Asthma Patients in the United StatesCompletedNCT05157087How we knowReport a problem
- Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients.Status unknownNCT05001529Phase 4How we knowReport a problem
- Measuring Omalizumab Responses Using Real-world Evidence (MORRE) StudyStatus unknownNCT04724278How we knowReport a problem
- Similarities and Differences of Biological Therapies for Severe Asthma.Status unknownNCT04665141How we knowReport a problem
- Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional TherapiesCompletedNCT04648930How we knowReport a problem
- Real Life Use of Omalizumab in Chronic UrticariaStatus unknownNCT04584190How we knowReport a problem
- Real-life Study of How to Intensify Treatment With Xolair (OMALIZUMAB) in Chronic Spontaneous UrticariaCompletedNCT04583475How we knowReport a problem
- Asthma Research in Children and AdolescentsActive, not recruitingNCT04480242How we knowReport a problem
- BIOmarkers in Severe AsthMa Patients on Omalizumab TreatmentCompletedNCT03361111How we knowReport a problem
- Effects of Omalizumab Compared to Non-Omalizumab Treatment in Asthma PatientsStatus unknownNCT02921178How we knowReport a problem
- The REALITY Study - a Real-life Long-term Analysis of Xolair TherapyStatus unknownNCT01776177How we knowReport a problem
- Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and HospitalizationsWithdrawnNCT01460862How we knowReport a problem
- Retrospective Study for Description of The Use Of Omalizumab In Patients With Difficult To Control AsthmaStatus unknownNCT01397760How we knowReport a problem
- Correlation Between IgE Parameters and the Response to Omalizumab in Subjects With Severe AsthmaWithdrawnNCT01002976How we knowReport a problem
- ICATA Asthma Mechanistic StudyCompletedNCT00377390How we knowReport a problem
- An Observational Study of the Use and Safety of Xolair® During PregnancyCompletedNCT00373061How we knowReport a problem
- Impact of Asthma Treatments on Daily ActivitiesStatus unknownNCT00350376How we knowReport a problem
- A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe AsthmaCompletedNCT00252135How we knowReport a problem